La cadena de opciones muestra datos clave de las opciones de acciones de Waldencast a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Waldencast..

Waldencast (NASDAQ:WALD) Bolsa, Cadena de Opciones

Waldencast

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Waldencast PLC

<a href="https://www.bloomberg.com/news/articles/2025-05-12/amc-to-slash-movie-ticket-prices-by-50-on-wednesdays?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-12/amc-to-slash-movie-ticket-prices-by-50-on-wednesdays?embedded-checkout=true</a>

News

General

'AMC to Slash Movie Ticket Prices by 50% on Wednesdays'- Bloomberg

Barclays analyst Julian Mitchell maintains Kennametal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) with a Equal-Weight and raises the price target from $22 to $24.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Kennametal, Raises Price Target to $24

Guidance

BSLK

Bolt Projects Holdings Sees FY2026 Revenue To Be At Least $9M

Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) affirms FY2025 sales outlook from $450.00 million-$475.00 million to $450.00 million-$475.00 million vs $462.97 million estimate.

MVST

Microvast Holdings Affirms FY2025 Sales Guidance of $450.00M-$475.00M vs $462.97M Est

Bolt Projects Holdings Sees FY2025 Revenue Of Atleast $4.5M

Copart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) has outperformed the market over the past 15 years by 12.98% on an annualized basis producing an average annual return of 24.58%. Currently, Copart has a market capitalization of $60.14 billion. 
Buying $100 In CPRT: If an investor had bought $100 of CPRT stock 15 years ago, it would be worth $2,674.99 today based on a price of $62.25 for CPRT at the time of writing.
<h3>Copart's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747084514_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CPRT

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Village Farms International Announces Transformative Transaction to Privatize Its Fresh Produce Business; Village Farms' Fresh Segment To Become Cornerstone Of Newco's Commercial Operations And Growth Strategy; Expects To Receive $40M In Cash Proceeds; 37.9% Equity Ownership Interest In Newco; Retains Ownership Of All Canadian Cultivation Assets

Bolt Projects Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>) reported quarterly losses of $(3.00) per share. This is a 89.37 percent increase over losses of $(28.22) per share from the same period last year. The company reported $171.00 thousand in sales this quarter. This is a 800.00 percent increase over sales of $19.00 thousand the same period last year.

Earnings

Bolt Projects Holdings Q1 EPS $(3.00) Up From $(28.22) YoY, Sales $171.00K Up From $19.00K YoY

Central Puerto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CEPU#NYSE">CEPU</a>) reported quarterly earnings of $0.50 per share. This is a 150 percent increase over earnings of $0.20 per share from the same period last year. The company reported $196.00 million in sales this quarter. This is a 130.67M percent increase over sales of $150.00 the same period last year.

CEPU

Central Puerto Q1 EPS $0.50 Up From $0.20 YoY, Sales $196.00M Up From $150.00 YoY

Barclays analyst Adrienne Yih maintains Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) with a Overweight and lowers the price target from $38 to $23.

VSCO

Barclays Maintains Overweight on Victoria's Secret, Lowers Price Target to $23

Legacy Housing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGH#NASDAQ">LEGH</a>) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.57 by 24.56 percent. This is a 28.33 percent decrease over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $35.70 million which missed the analyst consensus estimate of $43.13 million by 17.23 percent. This is a 17.44 percent decrease over sales of $43.24 million the same period last year.

Earnings Misses

LEGH

Legacy Housing Q1 EPS $0.43 Misses $0.57 Estimate, Sales $35.70M Miss $43.13M Estimate

LSEAW

Trading Halt: Halted at 5:12:38 p.m. ET - Trading Halt: Halt News Pending

LSEA

EVI Industries (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EVI#AMEX">EVI</a>) reported quarterly earnings of $0.07 per share. This is a 16.67 percent increase over earnings of $0.06 per share from the same period last year. The company reported $93.54 million in sales this quarter. This is a 11.38 percent increase over sales of $83.98 million the same period last year.

EVI Industries Q3 EPS $0.07 Up From $0.06 YoY, Sales $93.54M Up From $83.98M YoY

Barclays analyst Adrienne Yih maintains VF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) with a Overweight and lowers the price target from $34 to $19.

Barclays Maintains Overweight on VF, Lowers Price Target to $19

Tecogen (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TGEN#AMEX">TGEN</a>) reported quarterly losses of $(0.03) per share. This is a 25 percent increase over losses of $(0.04) per share from the same period last year. The company reported $7.28 million in sales this quarter. This is a 17.65 percent increase over sales of $6.19 million the same period last year.

TGEN

Tecogen Q1 EPS $(0.03) Up From $(0.04) YoY, Sales $7.28M Up From $6.19M YoY

Barclays analyst Adrienne Yih maintains Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) with a Overweight and lowers the price target from $68 to $59.

URBN

Barclays Maintains Overweight on Urban Outfitters, Lowers Price Target to $59

DRI HEALTHCARE TRUST Q1 Adj. EPS $0.43 Misses $0.51 Estimate, Sales $44.03M Miss $44.12M Estimate

Barnwell Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRN#NYSE">BRN</a>) ("Barnwell" or the "Company") today urged shareholders to follow the recommendation by leading proxy advisory firm Institutional Shareholder Services Inc. ("ISS") in its May 7, 2025, report in which it recommended just one candidate, Heather Isidoro, from the slate put forward by Ned Sherwood and his affiliates (the "Sherwood Group").

Management

Barnwell Industries Urges Shareholders To Vote In Accordance With ISS Recommendation And Reject Ned Sherwood's Attempt To Take Over the Company

WhiteHorse Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHF#NASDAQ">WHF</a>) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.34 by 13.53 percent. This is a 36.77 percent decrease over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $18.80 million which missed the analyst consensus estimate of $20.43 million by 7.96 percent. This is a 26.20 percent decrease over sales of $25.48 million the same period last year.

WhiteHorse Finance Q1 Core net investment income per share $0.29 Misses $0.34 Estimate, Total investment income $18.80M Miss $20.43M Estimate

Press Releases

Waldencast Announces Participation in the ICR Conference 2025

Milk Makeup to Launch at Ulta Beauty This Spring

Waldencast Announces Participation in the 2025 IMCAS World Congress

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates

Health Care

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection

Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast

Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream

Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

WALD

AXIL Brands

BellRing Brands

Coty

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

Estee Lauder Companies, Inc. (The) Common Stock

Estee Lauder Cos

e.l.f. Beauty

Edgewell Personal Care Company Common Stock

Edgewell Personal Care

FitLife Brands

Herbalife

Honest Co

Interparfums

Kenvue

Lifevantage

Medifast

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Olaplex Hldgs

Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares

Paranovus Entertainment

The Beauty Health Company - Class A Common Stock

Beauty Health

United-Guardian

Unilever

Upexi

Usana Health Sciences

Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares

Comments

Waldencast

Waldencast (WALD) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL